Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study
NCT04721418 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-09-11
Summary
The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.
Conditions
- Cocaine Use Disorder
- Healthy Controls
Interventions
- RADIATION
-
11C-UCB-J
11C-UCB-J PET scan
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Gustavo Angarita, MD · Yale University
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-20
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
NCT06125054 ·Status: RECRUITING ·Phase: PHASE2
-
Cocaine Use Disorder and Cortical Dopamine
NCT03349606 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419 ·Status: SUSPENDED ·Phase: PHASE3
-
Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction
NCT01978457 ·Status: TERMINATED ·Phase: PHASE1
-
Longitudinal Assessment of Functional Connectivity in Treatment Engaged Cocaine Users
NCT03554928 ·Status: COMPLETED
-
Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
NCT01984177 ·Status: COMPLETED
-
Alterations in Serotonergic Functions in Cocaine Addicts - 1
NCT00000312 ·Status: COMPLETED ·Phase: PHASE1
-
Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence
NCT02994875 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction
NCT02626494 ·Status: COMPLETED ·Phase: PHASE4
-
Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial
NCT02373124 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Glutamatergic Modulation of Cocaine-related Deficits
NCT01790490 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET
NCT02152670 ·Status: TERMINATED ·Phase: NA
-
Brain Imaging Studies of the Effects of Cocaine Abstinence
NCT00581282 ·Status: WITHDRAWN
-
The Effect of Glutamatergic Modulation on Cocaine Self-administration
NCT02596022 ·Status: COMPLETED ·Phase: PHASE2
-
Glutaminergic Agents for Cocaine Abuse - 5
NCT00000280 ·Status: COMPLETED ·Phase: PHASE1
-
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
NCT05011760 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Brain Glutamate Receptors and Cocaine Dependence
NCT00951314 ·Status: TERMINATED
-
Brain Function and Structure in Cocaine Dependence
NCT02080832 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
NCT00376558 ·Status: COMPLETED ·Phase: NA
-
Brain Imaging of Cocaine Craving in Recreational Cocaine Users
NCT01189578 ·Status: COMPLETED
-
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901 ·Status: COMPLETED ·Phase: PHASE2
-
[11C]NOP-1A and Cocaine Use Disorders
NCT03348384 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
NCT00000315 ·Status: COMPLETED ·Phase: PHASE1
-
PET Assays of Striatal Dopamine Marker in Cocaine Craving
NCT01036516 ·Status: COMPLETED
-
Functional Connectivity Changes During Early Recovery as a Marker for Relapse
NCT02861820 ·Status: COMPLETED